Atlas Trials

Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder

Clinical trial NCT00322595 · COMPLETED

Trial details

NCT number
NCT00322595
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Generalized Anxiety Disorder
Start date
2006-05-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.